Palumbo Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.29M Sell
4,558
-74
-2% -$35.5K 0.48% 44
2026
Q1
$2.28M Sell
4,632
-956
-17% -$519K 0.56% 41
2025
Q4
$3.24M Buy
5,588
+42
+0.8% +$23.8K 0.8% 31
2025
Q3
$2.61M Buy
5,546
+183
+3% +$85.2K 0.83% 32
2025
Q2
$2.17M Buy
5,363
+309
+6% +$129K 0.67% 40
2025
Q1
$2.51M Buy
5,054
+1,459
+41% +$790K 0.84% 33
2024
Q4
$1.87M Sell
3,595
-478
-12% -$263K 0.7% 36
2024
Q3
$2.52M Buy
4,073
+103
+3% +$61K 0.98% 27
2024
Q2
$2.2M Buy
3,970
+351
+10% +$201K 0.93% 28
2024
Q1
$2.1M Buy
3,619
+837
+30% +$470K 0.94% 29
2023
Q4
$1.48M Buy
2,782
+274
+11% +$133K 0.75% 32
2023
Q3
$1.27M Buy
2,508
+896
+56% +$477K 0.7% 34
2023
Q2
$841K Buy
+1,612
New +$870K 0.51% 40

Other funds holding TMO

Palumbo Wealth Management's TMO Position: Q2 2026 in Review

Palumbo Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 1.6% in Q2 2026, selling an estimated $35.5K and leaving 4,558 shares worth $2.29M. The position accounts for 0.48% of the portfolio, ranked #44.

Palumbo Wealth Management first reported a position in TMO in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.24M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Palumbo Wealth Management held 4,558 shares of Thermo Fisher Scientific worth $2.29M as of Q2 2026.
  • Palumbo Wealth Management sold 74 Thermo Fisher Scientific shares in Q2 2026, an estimated $35.5K.
  • Thermo Fisher Scientific made up 0.48% of Palumbo Wealth Management's portfolio in Q2 2026, its #44 holding.
  • Palumbo Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 13 quarters since.
  • Palumbo Wealth Management's Thermo Fisher Scientific position peaked at $3.24M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.